Patriot Pharmaceuticals

What Patriot Pharmaceuticals does

Patriot Pharmaceuticals, LLC is a Pennsylvania-based limited liability company and a wholly owned subsidiary of Janssen Pharmaceuticals, Inc., itself part of the Johnson & Johnson corporate family. The company is engaged in the sale and distribution of generic pharmaceutical products in the United States. Its product portfolio consists of five authorized generic medications covering four therapeutic areas: Etravirine tablets (antiretroviral for HIV infection, generic of INTELENCE), Itraconazole capsules (antifungal, generic of SPORANOX), Miglustat capsules (enzyme substrate reduction therapy for Type 1 Gaucher disease, generic of ZAVESCA), and Risperidone oral solution (antipsychotic for schizophrenia, generic of RISPERDAL). Each product carries an assigned NDC code and is supplied in standardized packaging configurations.

The business operates a passive distribution model rather than a manufacturing operation. Patriot markets and sells these generics through an authorized distributor network that includes the three largest US pharmaceutical wholesalers (AmerisourceBergen, McKesson, Cardinal Health), major retail pharmacy chains (CVS Health, Walgreens, Rite Aid, The Kroger Company), and numerous regional distributors. Its stated value proposition is to deliver "reliable and competitively priced generic pharmaceutical products" backed by the brand credibility and operational support of the Johnson & Johnson enterprise. The company does not publish pricing, has no publicly disclosed revenue, and operates with a very small staff (reportedly 1-10 employees).

Patriot serves healthcare providers and patients in the United States and its territories only; international use is explicitly disclaimed. Go-to-market is exclusively B2B through distributors rather than direct-to-customer. Marketing communications are compliance-focused (transparency disclosures, physician payment reporting, educational grants, charitable contributions) rather than promotional. The site is published by Johnson & Johnson Health Care Systems Inc., confirming that operational, regulatory, and reputational control sits at the J&J parent level.

Name

Patriot Pharmaceuticals

Legal name

Patriot Pharmaceuticals, LLC

Website

https://patriotpharmaceuticals.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

1–10 employees

Short description

Patriot Pharmaceuticals, LLC is a wholly owned subsidiary of Janssen Pharmaceuticals (Johnson & Johnson) that distributes five authorized generic pharmaceuticals (Etravirine, Itraconazole, Miglustat, Risperidone) in the United States through an authorized distributor network of major wholesalers and retail pharmacy chains.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Authorized Generics (HLAIABAK)

akta.pro secondary industries

Small-Molecule Generics (Branded/Unbranded) (HLAIABAA), Infectious Disease Specialty Pharmaceuticals (Non-vaccine) (HLAIACAM), Neurology & CNS Specialty Pharmaceuticals (HLAIACAC)

Keywords

• Generic pharmaceuticals
• Antiretroviral medications
• Antifungal medications
• Pharmaceutical distribution
• Generic drug sales

Headquarters

HQ city

Horsham

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Marketing or Sales, Personnel, Others

Revenue model

1. Generic Pharmaceutical Sales: Sale and distribution of generic pharmaceuticals through authorized distribution channels. Patriot Pharmaceuticals operates as a wholly owned subsidiary of Janssen Pharmaceuticals, Inc. and generates revenue through the sale of generic versions of branded pharmaceutical products including antiretroviral agents (Etravirine), antifungals (Itraconazole), enzyme inhibitors (Miglustat), and psychiatric medications (Risperidone).

Go-to-market motion1 record

Distribution channels12 records

Marketing channels2 records

Core offering

Patriot Pharmaceuticals sells and distributes a portfolio of authorized generic prescription pharmaceuticals in the United States, acting as a wholly owned subsidiary of Janssen Pharmaceuticals, Inc. Its catalog covers generics of established branded medications used in HIV/AIDS treatment (Etravirine), fungal infections (Itraconazole), Gaucher disease (Miglustat), and psychiatric conditions (Risperidone), delivered exclusively through authorized pharmaceutical wholesalers and major pharmacy chains.

Product overview

Patriot Pharmaceuticals is a wholly owned subsidiary of Janssen Pharmaceuticals (Johnson & Johnson) engaged in the sale and distribution of generic pharmaceuticals. The company is strategically positioned in Horsham, PA to deliver reliable and competitively priced generic pharmaceutical products. The product portfolio consists of five authorized generic medications: Etravirine 100mg and 200mg tablets (antiretroviral for HIV), Itraconazole 100mg capsules (antifungal), Miglustat 100mg capsules (for Gaucher disease), and Risperidone 1mg/mL oral solution (antipsychotic). These generics serve as authorized equivalents to brand-name drugs including INTELENCE, SPORANOX, ZAVESCA, and RISPERDAL.

Differentiator

Problem solved

Functional benefit

Products and services

• Etravirine 100mg Tablet

Segments1 record

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered core.

• Janssen Pharmaceuticals, Inc.coreOthersPatriot Pharmaceuticals is a wholly owned subsidiary of Janssen Pharmaceuticals, Inc. The subsidiary relationship provides corporate structure, brand association, and operational support within the Johnson & Johnson family of companies.
• Johnson & JohnsoncoreOthersJohnson & Johnson and its affiliates own Patriot Pharmaceuticals through Janssen Pharmaceuticals. The site is published by Johnson & Johnson Health Care Systems Inc., which is solely responsible for its contents.

Scale indicators1 record

Recent moves3 records

Direct peers

• Prasco Laboratories: Prasco specializes in authorized generics of major branded pharmaceuticals, making it the closest functional peer to Patriot. Both companies distribute authorized-generic versions of brand-name drugs through US pharmaceutical channels.
• Breckenridge Pharmaceutical: Breckenridge manufactures and distributes generic prescription pharmaceuticals in the US, including authorized generics. Comparable product portfolio strategy and distribution through US wholesalers.
• Greenstone LLC: Greenstone is Pfizer's authorized generics subsidiary, structurally identical to Patriot as a pharma-major subsidiary distributing its parent's authorized generics. Directly comparable operating model and market position.

Emerging players

• Lupin Pharmaceuticals: Lupin's US business distributes a broad range of generic prescription products through major wholesalers, overlapping with Patriot's distribution model and therapeutic categories.
• Aurobindo Pharma USA: Aurobindo's US subsidiary is a fast-growing generic pharmaceutical player with broad therapeutic-area overlap, particularly in infectious disease and CNS generics, competing on price in shared channels.
• Amneal Pharmaceuticals: Amneal is a US-focused generic and specialty pharmaceutical company with portfolio overlap in CNS and other chronic-therapy generics, increasingly competitive in the authorized-generic and traditional generic space.

Broad incumbents

• Teva Pharmaceutical Industries: Teva is a global leader in generic pharmaceuticals with an extensive US generics business that overlaps with Patriot's therapeutic categories. Operates as a much larger, diversified generic incumbent.
• Sandoz (Novartis): Sandoz is one of the world's largest generic pharmaceutical companies, offering a broad generic portfolio that competes with Patriot across multiple therapeutic categories including antifungals and central nervous system medications.
• Apotex Corp: Apotex is a large Canadian-headquartered generic manufacturer with significant US generic distribution operations, offering direct competition to Patriot's product categories.
• Viatris: Viatris (formed from Mylan and Upjohn) is a major US generic pharmaceutical player with broad portfolio overlap in HIV, antifungal and CNS therapeutics where Patriot operates.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Patriot Pharmaceuticals